Search research articles
Contact Us
Filters
Showing results (301-310 of 315) with videos related to
Page
of 32
Sort By:
Science Translational Medicine
|
October 19, 2022
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple <i>Plasmodium</i> kinases and life cycle stages
Lauren B Arendse, James M Murithi, Tarrick Qahash, et al.
Cell Chemical Biology
|
May 4, 2020
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
Manu Vanaerschot, James M Murithi, Charisse Flerida A Pasaje, et al.
Nature Communications
|
January 12, 2021
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
Janette Reader, Mariëtte E van der Watt, Dale Taylor, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against <i>Plasmodium falciparum</i> via Dual Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation
Kathryn J Wicht, John G Woodland, Larnelle F Garnie, et al.
Angewandte Chemie (International Ed. in English)
|
May 3, 2025
The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria
John G Woodland, Dina Coertzen, Kathryn J Wicht, et al.
ACS Chemical Biology
|
June 13, 2026
The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite <i>Plasmodium falciparum</i> via Polypharmacological Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation
Kathryn J Wicht, John G Woodland, Larnelle F Garnie, et al.
Cell Chemical Biology
|
July 7, 2021
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
James M Murithi, Ioanna Deni, Charisse Flerida A Pasaje, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies
Colin R Wilson, Richard K Gessner, Atica Moosa, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy
Godwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 315) with videos related to
Sort By:
Page
of 32
Science Translational Medicine
|
October 19, 2022
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple <i>Plasmodium</i> kinases and life cycle stages
Lauren B Arendse, James M Murithi, Tarrick Qahash, et al.
Cell Chemical Biology
|
May 4, 2020
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
Manu Vanaerschot, James M Murithi, Charisse Flerida A Pasaje, et al.
Nature Communications
|
January 12, 2021
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
Janette Reader, Mariëtte E van der Watt, Dale Taylor, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against <i>Plasmodium falciparum</i> via Dual Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation
Kathryn J Wicht, John G Woodland, Larnelle F Garnie, et al.
Angewandte Chemie (International Ed. in English)
|
May 3, 2025
The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria
John G Woodland, Dina Coertzen, Kathryn J Wicht, et al.
ACS Chemical Biology
|
June 13, 2026
The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite <i>Plasmodium falciparum</i> via Polypharmacological Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation
Kathryn J Wicht, John G Woodland, Larnelle F Garnie, et al.
Cell Chemical Biology
|
July 7, 2021
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
James M Murithi, Ioanna Deni, Charisse Flerida A Pasaje, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies
Colin R Wilson, Richard K Gessner, Atica Moosa, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy
Godwin Akpeko Dziwornu, Donald Seanego, Stephen Fienberg, et al.
Page
of 32